Company / Current Liabilities
ImmunityBio, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$61.8M
FY2025
5-year range
$54.9M / $500.9M
FY2021-FY2025
Trend
+12.4%
vs FY2024
Sector context
#128 of 213
Health Care
What the data says
At $62M, ImmunityBio, Inc.'s current liabilities ranks #86 of 213 in the Health Care sector. Current Liabilities returned to growth in FY2025 after 2 years of decline, reaching $62M.
Based on SEC 10-K filings.
$62M in FY2025 with a 5-year CAGR of -1.9%.
Increased from $58M to $62M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -50.2%
- 5-Year CAGR
- -1.9%
- 10-Year CAGR
- -
Sector benchmark
#86 of 213 in Health CareTop 40% of 213This company $61.8M Sector average $1.6B
▼
-96.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -1.9%, indicating a declining trend.
- In FY2025, current liabilities increased 12.4% year-over-year.
- Ranks #128 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $61.8M | +12.4% |
| FY2024 | $54.9M | -5.7% |
| FY2023 | $58.3M | -88.4% |
| FY2022 | $500.9M | +35.7% |
| FY2021 | $369.0M | +441.6% |
| FY2020 | $68.1M | +489.4% |
| FY2019 | $11.6M | -57.6% |
| FY2018 | $27.3M | +30.6% |
| FY2017 | $20.9M | +66.2% |
| FY2016 | $12.6M | +104.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026